Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis;Impacto de la trombolisisy de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios

Revista Medica de Chile

Volumn 136, Issue 9, 2008, Pages 1098-1106

  Greig, Douglas ^a   Corbalán, Ramón ^a   Castro, Pablo ^a   Campos, Pabla ^b   Lamích, Rubén ^c   Yovaniniz, Patricio ^c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Hospital de Urgencia Asistencia Pública Doctor Alejandro del Rio   (Chile)

^c HOSPITAL BARROS LUCO TRUDEAU   (Chile)

Author keywords

Angioplasty; Myocardial infarction; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TIME;

ADULT; AGE DISTRIBUTION; AGED; ANGIOPLASTY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 56349153976     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Departamento de Estadísticas e Información en Salud. Ministerio de Salud de Chile 2007; URL: http//deis.minsal.cl/index.asp.
2. KEELEY EC, BOURA JA, GRINES CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361: 13-20.
3. NALLAMOTHU B, FOX KA, KENNELLY BM, VAN DE WF, GORE JM, STEG PG ET AL. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007; 93: 1552-5.
4. CHAMORRO H, DUCCI H, MATHEI R, ALCAÍNO M, FLORENZANO F, RAMÍREZ A ET AL. Angioplastia coronaria primaria como tratamiento de elección en las primeras 6 horas del infarto de miocardio. Rev Méd Chile 1995; 123: 727-34.
5. CORBALÁN R, NAZZAL C, PRIETO JC, CHÁVEZ E, LANAS F, LAMICH R ET AL. Reducción de la mortalidad por infarto del miocardio en hospitales chilenos. Rev Méd Chile 2002; 130: 368-78.
6. PRIETO JC, CORBALÁN R, CHÁVEZ E, LANAS F, CUMSILLE F, NAZZAL C. Infarto agudo del miocardio en hospitales chilenos: resultados finales del estudio GEMI. Rev Méd Chile 1999; 127: 763-74.
7. CORBALÁN R, PRIETO JC, CHÁVEZ, MD, NAZZAL C, CUMSILLE F, KRUCOFF M. Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis. Am Heart J 1999; 138: 533-9.
8. MORROW DA, ANTMAN EM, CHARLESWORTH A, CAIRNS R, MURPHY SA, DE LEMOS JA ET AL. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-7.
9. DEGEARE VS, BOURA JA, GRINES LL, O'NEILL WW, GRINES CL. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001; 87: 1035-8.
10. GIBSON CM. NRMI and current treatment patterns for ST-elevation myocardial infarction. Am Heart J 2004; 148: S29-S33.
11. WEAVER WD, SIMES RJ, BETRIU A, GRINES CL, ZIJLSTRA F, GARCÍA E ET AL. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-8.
12. BOERSMA E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27: 779-88.
13. BJORKLUND E, LINDAHL B, STENESTRAND U, SWAHN E, DELLBORG M, PEHRSSON K ET AL. Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. Am Heart J 2004; 148: 566-73.
14. ROGERS WJ, CANTO JG, LAMBREW CT, TIEFENBRUNN AJ, KINKAID B, SHOULTZ DA ET AL. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
15. DE LG, SURYAPRANATA H, DAMBRINK JH, OTTERVANGER JP, VAN'T HOF AW, ZIJLSTRA F ET AL. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction Study. Am Heart J 2004; 148: 852-6.
16. KOSUGE M, KIMURA K, KOJIMA S, SAKAMOTO T, ISHIHARA M, ASADA Y ET AL. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J 2006; 70: 217-21.
17. MAHON NG, MCKENNA CJ, CODD MB, O'RORKE C, MCCANN HA, SUGRUE DD. Gender differences in the management and outcome of acute myocardial infarction in unselected patients in the thrombolytic era. Am J Cardiol 2000; 85: 921-6.
18. MALACRIDA R, GENONI M, MAGGIONI AP, SPATARO V, PARISH S, PALMER A ET AL. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med 1998; 338: 8-14.
19. VACCARINO V, PARSONS L, EVERY NR, BARRON HV, KRUMHOLZ HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-25.
20. WIDIMSKY P, ZELIZKO M, JANSKY P, TOUSEK F, HOLM F, ASCHERMANN M. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol 2007; 119: 212-9.
21. ANDERSON JL, KARAGOUNIS LA, MUHLESTEIN JB. Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for acute myocardial infarction. Am J Cardiol 1996; 78: 934-9.
22. FOX KA, STEG PG, EAGLE KA, GOODMAN SG, ANDERSON FA JR., GRANGER CB ET AL. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 1892-900.
23. PRIETO JC, CORBALÁN R, NAZZA C, CHÁVEZ E, LANAS F, BARTOLUCCI J, CUMSILLE F. Cambios en los patrones de prescripción de medicamentos en el infarto agudo del miocardio. Comparación de dos períodos. Rev Méd Chile 2001; 129: 481-8.
24. CORBALÁN R, LARRÁN G, NAZZAL G, CASTRO P, ACEVEDO M, DOMÍNGUEZ JM ET AL. Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2001; 88: 342-6.
25. PINTO DS, KIRTANE AJ, NALLAMOTHU BK, MURPHY SA, COHEN DJ, LAHAM RJ ET AL. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006; 114: 2019-25.
26. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349-60.
27. STEG PG, LÓPEZ-SENDON J, ĹPEZ DE SE, GOODMAN SG, GORE JM, ANDERSON FA ET AL. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007; 167: 68-73.